Saito Norio, Koda Keiji, Takiguchi Nobuhiro, Oda Kenji, Ono Masato, Sugito Masanori, Kawashima Kiyotaka, Ito Masaaki
Department of Surgical Oncology, National Cancer Center Hospital East, Chiba University School of Medicine, Chiba, Japan.
Dig Surg. 2003;20(3):192-9; discussion 200. doi: 10.1159/000070385.
BACKGROUND/AIMS: Local pelvic recurrence of rectal cancer after radical resection has been associated with morbidity and cancer-related death. This study retrospectively evaluated outcome following curative resection for rectal cancer recurring after surgery on the basis of prognosis, type of procedure and perioperative morbidity.
A total of 85 consecutive patients with local pelvic recurrence of rectal cancer were evaluated. Of these, 43 underwent microscopic curative surgery for local recurrence. Among the 43 patients, 23 underwent surgery alone and 17 received preoperative radiotherapy (40 Gy) (XRT group) in addition to the surgery. Of the 43 patients, 26 were asymptomatic.
Curative resection was higher in the recurrences that were associated with implantation, incomplete surgical margin clearance, and intrapelvic lymph node metastasis than in other types of recurrence. With regard to surgical procedure, abdominoperineal resection (APR), with or without sacral resection, was standard following previous sphincter-preserving surgery, while total pelvic exenteration (TPE), with or without sacral resection, was common following previous APR. Local excision was not considered appropriate surgery. There was a high incidence of perioperative morbidity (64%) in patients receiving TPE. Re-recurrence was observed in 18 patients (50%) after curative surgery. After a follow-up of 2 years or more, the local re-recurrence rate was 28%. The overall 5-year survival rate for patients receiving curative resection was 39%, for patients in the XRT group, 51%, and for patients in the surgery-alone group, 24% (p = 0.07). The survival rate in 26 asymptomatic patients was higher than in 17 patients with symptoms, with 5-year survival rates of 62 and 23% (p < 0.05), respectively. The cumulative local control in the preoperative radiotherapy plus en bloc surgery group (XRT group) was significantly better than in the surgery-alone group (p < 0.01), and survival in the XRT group tended to be better than in surgery alone.
These results suggest that careful patient selection according to the pattern of recurrence, area of invasion and presence of symptoms is important for successful curative surgery. Aggressive surgery with adjuvant therapy may lead to an improved salvage rate.
背景/目的:直肠癌根治性切除术后盆腔局部复发与发病及癌症相关死亡有关。本研究基于预后、手术类型和围手术期发病率,对手术后复发的直肠癌进行根治性切除后的结果进行回顾性评估。
共评估了85例连续的直肠癌盆腔局部复发患者。其中,43例接受了局部复发的显微根治性手术。在这43例患者中,23例仅接受了手术,17例除手术外还接受了术前放疗(40 Gy)(XRT组)。43例患者中,26例无症状。
与种植、手术切缘清扫不彻底和盆腔内淋巴结转移相关的复发患者的根治性切除率高于其他类型的复发。关于手术方式,在先前保留括约肌手术之后,腹会阴联合切除术(APR),无论是否进行骶骨切除,都是标准术式;而在先前APR之后,全盆腔脏器切除术(TPE),无论是否进行骶骨切除,都较为常见。局部切除术不被认为是合适的手术方式。接受TPE的患者围手术期发病率较高(64%)。根治性手术后,18例患者(50%)出现再次复发。随访2年或更长时间后,局部再次复发率为28%。接受根治性切除患者的总体5年生存率为39%,XRT组患者为51%,单纯手术组患者为24%(p = 0.07)。26例无症状患者的生存率高于17例有症状患者,5年生存率分别为62%和23%(p < 0.05)。术前放疗加整块切除手术组(XRT组)的累积局部控制明显优于单纯手术组(p < 0.01),且XRT组的生存率倾向于高于单纯手术组。
这些结果表明,根据复发模式、侵犯范围和症状情况仔细选择患者对于成功进行根治性手术很重要。积极的手术联合辅助治疗可能会提高挽救率。